A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease
H. Kobayashi (Shizuoka, Japan), T. Naito (Shizuoka, Japan), S. Omori (Shizuoka, Japan), K. Nakashima (Shizuoka, Japan), K. Wakuda (Shizuoka, Japan), A. Ono (Shizuoka, Japan), H. Kenmotsu (Shizuoka, Japan), H. Murakami (Shizuoka, Japan), M. Endo (Shizuoka, Japan), T. Takahashi (Shizuoka, Japan)
Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2227
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Kobayashi (Shizuoka, Japan), T. Naito (Shizuoka, Japan), S. Omori (Shizuoka, Japan), K. Nakashima (Shizuoka, Japan), K. Wakuda (Shizuoka, Japan), A. Ono (Shizuoka, Japan), H. Kenmotsu (Shizuoka, Japan), H. Murakami (Shizuoka, Japan), M. Endo (Shizuoka, Japan), T. Takahashi (Shizuoka, Japan). A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease. 2227
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Do cavitating non-small cell lung cancer patients have a more aggressive disease? Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Does the lung function affect the survival time in patients with resected non-small cell lung cancer? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007
Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 771s Year: 2006
How to handle oligometastatic disease in nonsmall cell lung cancer Source: Eur Respir Rev, 30 (159) 200234; 10.1183/16000617.0234-2020 Year: 2021
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020
Management of brain metastases in patients with non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
Lung cancer Source: Respipedia Article Year: 2018
Influence of the lung resection to small airways function in patients with limited and normal lung function and primary non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006
Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006
Advanced non-small cell lung cancer in elderly patients Source: Breathe 2012; 9: 26-34 Year: 2012
Radio(chemo)therapy in locally advanced nonsmall cell lung cancer Source: Eur Respir Rev 2015; 25: 65-70 Year: 2016
Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010
Physical Activity patients following lung resection for non-small cell lung cancer Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017
Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006
Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018
Metastatic disease in non-small cell lung cancer: is it all the same? Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Effect of comorbidity on the prognosis of non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 385s Year: 2006